Speed Medical results, Q4 2024
Net profit, assets, equity and cash flow for Q4 2024, against the same period a year earlier, from the published financial statements.
Net profit-48.8 millionEGP · +0.4% vs the same period a year earlier
Total assets458 millionEGP · −18.9% vs the same period a year earlier
Shareholders' equity227 millionEGP · −2.4% vs the same period a year earlier
Operating cash flow-46.3 millionEGP · −275.1% vs the same period a year earlier
In short
- Speed Medical's net profit for Q4 2024 was about -48.8 million EGP, up +0.4% from -49.01 million EGP in Q4 2023.
- Total assets at the end of Q4 2024 were about 458 million EGP, and shareholders' equity about 227 million EGP.
- Operating cash flow for Q4 2024 was negative at 46.3 million EGP.
Key lines against the same period a year earlier
This periodQ4 2023Change
Net profit-48.8 million-49.01 million+0.4%
Gross profit-6.9 million-2.84 million−142.6%
Total assets458 million566 million−18.9%
Total liabilities232 million333 million−30.5%
Shareholders' equity227 million232 million−2.4%
Total liabilities and equity458 million566 million−18.9%
Operating cash flow-46.3 million26.44 million−275.1%
Investing cash flow40.67 million-5.62 million+824.4%
Financing cash flow4.26 million-21.04 million+120.2%
Net change in cash-1.36 million-211 thousand−546.9%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Speed Medical's Q2 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy